Download PDF
Horm Metab Res 2017; 49(01): 43-49
DOI: 10.1055/s-0042-116157
Endocrine Research
© Georg Thieme Verlag KG Stuttgart · New York

Elevated Steroid Hormone Production in the db/db Mouse Model of Obesity and Type 2 Diabetes

Anja Hofmann
1   Division of Vascular Endothelium and Microcirculation, Department of Medicine III, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany
,
Mirko Peitzsch
2   Division of Clinical Neurochemistry, Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany
,
Coy Brunssen
1   Division of Vascular Endothelium and Microcirculation, Department of Medicine III, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany
,
Jennifer Mittag
1   Division of Vascular Endothelium and Microcirculation, Department of Medicine III, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany
,
Annett Jannasch
3   Department of Cardiac Surgery, Herzzentrum Dresden, Medical Faculty Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany
,
Annika Frenzel
1   Division of Vascular Endothelium and Microcirculation, Department of Medicine III, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany
,
Nicholas Brown
4   Cardio Metabolic Diseases, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
,
Steven M. Weldon
4   Cardio Metabolic Diseases, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
,
Graeme Eisenhofer
2   Division of Clinical Neurochemistry, Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany
5   Department of Medicine III, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany
,
Stefan R. Bornstein
5   Department of Medicine III, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany
6   Endocrinology and Diabetes, Division of Diabetes & Nutritional Sciences, Rayne Institute, Denmark Hill Campus, Faculty of Life Sciences & Medicine, Kings College London, London, UK
,
Henning Morawietz
1   Division of Vascular Endothelium and Microcirculation, Department of Medicine III, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany
5   Department of Medicine III, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany
› Author Affiliations
Further Information

Publication History

received 04 May 2016

accepted 23 August 2016

Publication Date:
03 November 2016 (online)

Also available at
    Permissions and Reprints

Abstract

Obesity and type 2 diabetes have become a major public health problem worldwide. Steroid hormone dysfunction appears to be linked to development of obesity and type 2 diabetes and correction of steroid abnormalities may offer new approaches to therapy. We therefore analyzed plasma steroids in 15–16 week old obese and diabetic db/db mice using liquid chromatography-tandem mass spectrometry. Lean db/+ served as controls. Db/db mice developed obesity, hyperglycemia, hyperleptinemia, and hyperlipidemia. Hepatic triglyceride storage was increased and adiponectin and pancreatic insulin were lowered. Aldosterone, corticosterone, 11-deoxycorticosterone, and progesterone were respectively increased by 3.6-, 2.9-, 3.4, and 1.7-fold in db/db mice compared to controls. Ratios of aldosterone-to-progesterone and corticosterone-to-progesterone were respectively 2.0- and 1.5-fold higher in db/db mice. Genes associated with steroidogenesis were quantified in the adrenal glands and gonadal adipose tissues. In adrenals, Cyp11b2, Cyp11b1, Cyp21a1, Hsd3b1, Cyp11a1, and StAR were all significantly increased in db/db mice compared with db/+ controls. In adipose tissue, no Cyp11b2 or Cyp11b1 transcripts were detected and no differences in Cyp21a1, Hsd3b1, Cyp11a1, or StAR expression were found between db/+ and db/db mice. In conclusion, the present study showed an elevated steroid hormone production and adrenal steroidogenesis in the db/db model of obesity and type 2 diabetes.

Key words

aldosterone - diabetes mellitus type 2 - glucocorticoids - obesity - steroid hormones

Supporting Information

 

  • References

  • 1 Hsu HJ, Hsu NC, Hu MC, Chung BC. Steroidogenesis in zebrafish and mouse models. Mol Cell Endocrinol 2006; 248: 160-163
    CrossrefPubMedGoogle Scholar
  • 2 Rossier BC, Baker ME, Studer RA. Epithelial sodium transport and its control by aldosterone: the story of our internal environment revisited. Physiol Rev 2015; 95: 297-340
    CrossrefPubMedGoogle Scholar
  • 3 Moors M, Williams TA, Deinum J, Eisenhofer G, Reincke M, Lenders JW. Steroid hormone production in patients with aldosterone producing adenomas. Horm Metab Res 2015; 47: 967-972
    Google Scholar
  • 4 Garg R, Adler GK. Aldosterone and the mineralocorticoid receptor: Risk factors for cardiometabolic disorders. Curr Hypertens Rep 2015; 17: 52
    CrossrefPubMedGoogle Scholar
  • 5 Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res 2015; 116: 991-1006
    CrossrefPubMedGoogle Scholar
  • 6 Livingstone C, Collison M. Sex steroids and insulin resistance. Clin Sci (Lond) 2002; 102: 151-166
    CrossrefPubMedGoogle Scholar
  • 7 Maninger N, Wolkowitz OM, Reus VI, Epel ES, Mellon SH. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol 2009; 30: 65-91
    CrossrefPubMedGoogle Scholar
  • 8 Li J, Daly E, Campioli E, Wabitsch M, Papadopoulos V. De novo synthesis of steroids and oxysterols in adipocytes. J Biol Chem 2014; 289: 747-764
    CrossrefPubMedGoogle Scholar
  • 9 Catena C, Colussi G, Brosolo G, Novello M, Sechi LA. Aldosterone and left ventricular remodeling. Horm Metab Res 2015; 47: 981-986
    Google Scholar
  • 10 Ceral J, Malirova E, Ballon M, Solar M. The role of urinary aldosterone for the diagnosis of primary aldosteronism. Horm Metab Res 2014; 46: 663-667
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Saha S, Bornstein SR, Graessler J, Kopprasch S. Crosstalk between glycoxidative modification of low-density lipoprotein, angiotensin II-sensitization, and adrenocortical aldosterone release. Horm Metab Res 2015; 47: 855-860
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Viola A, Monticone S, Burrello J, Buffolo F, Lucchiari M, Rabbia F, Williams TA, Veglio F, Mengozzi G, Mulatero P. Renin and aldosterone measurements in the management of arterial hypertension. Horm Metab Res 2015; 47: 418-426
    Google Scholar
  • 13 Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981; 304: 930-933
    CrossrefPubMedGoogle Scholar
  • 14 Rafacho A, Ortsater H, Nadal A, Quesada I. Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes. J Endocrinol 2014; 223: R49-R62
    CrossrefPubMedGoogle Scholar
  • 15 London E, Lodish M, Keil M, Lyssikatos C, de la Luz Sierra M, Nesterova M, Stratakis CA. Not all glucocorticoid-induced obesity is the same: differences in adiposity among various diagnostic groups of Cushing syndrome. Horm Metab Res 2014; 46: 897-903
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978; 14: 141-148
    CrossrefPubMedGoogle Scholar
  • 17 Fredersdorf S, Endemann DH, Luchner A, Heitzmann D, Ulucan C, Birner C, Schmid P, Stoelcker B, Resch M, Muders F, Riegger GA, Weil J. Increased aldosterone levels in a model of type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2009; 117: 15-20
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Livingstone DE, Jones GC, Smith K, Jamieson PM, Andrew R, Kenyon CJ, Walker BR. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000; 141: 560-563
    CrossrefPubMedGoogle Scholar
  • 19 Dalboge LS, Almholt DL, Neerup TS, Vassiliadis E, Vrang N, Pedersen L, Fosgerau K, Jelsing J. Characterisation of age-dependent beta cell dynamics in the male db/db mice. PLoS One 2013; 8: e82813
    CrossrefPubMedGoogle Scholar
  • 20 Peitzsch M, Dekkers T, Haase M, Sweep FC, Quack I, Antoch G, Siegert G. Lenders JW, Deinum J, Willenberg HS, Eisenhofer G. An LC-MS/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism. J Steroid Biochem Mol Biol 2015; 145: 75-84
    Google Scholar
  • 21 Zhao Q, Hu X, Guo Q, Cui SW, Xian YX, You S, Chen X, Xu C, Gao X. Physicochemical properties and regulatory effects on db/db diabetic mice of β-glucans extracted from oat, wheat and barley. Food Hydrocolloids 2014; 37: 60-68
    CrossrefPubMedGoogle Scholar
  • 22 Langbein H, Brunssen C, Hofmann A, Cimalla P, Brux M, Bornstein SR, Deussen A, Koch E, Morawietz H. NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient mice. Eur Heart J 2016; 37: 1753-1761
    CrossrefPubMedGoogle Scholar
  • 23 Catar RA, Muller G, Brandt A, Langbein H, Brunssen C, Goettsch C, Frenzel A, Hofmann A, Goettsch W, Steinbronn N, Strasser RH, Schubert U, Ludwig B, Bornstein SR, Morawietz H. Increased gene expression of the cardiac endothelin system in obese mice. Horm Metab Res 2015; 47: 509-515
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Coleman DL. A historical perspective on leptin. Nat Med 2010; 16: 1097-1099
    CrossrefPubMedGoogle Scholar
  • 25 Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 2006; 87: 1-16
    CrossrefPubMedGoogle Scholar
  • 26 Blanchette S, Marceau P, Biron S, Brochu G, Tchernof A. Circulating Progesterone and Obesity in Men. Horm Metab Res 2006; 38: 330-335
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Kristiansen SB, Endoh A, Casson PR, Buster JE, Hornsby PJ. Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells. Steroids 1997; 62: 258-265
    CrossrefPubMedGoogle Scholar
  • 28 Lavoie HA, King SR. Transcriptional regulation of steroidogenic genes: STARD1, CYP11A1 and HSD3B. Exp Biol Med Maywood 2009; 234: 880-907
    CrossrefPubMedGoogle Scholar
  • 29 Briones AM, Nguyen Dinh Cat A, Callera GE, Yogi A, Burger D, He Y, Correa JW, Gagnon AM, Gomez-Sanchez CE, Gomez-Sanchez EP, Sorisky A, Ooi TC, Ruzicka M, Burns KD, Touyz RM. Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension 2012; 59: 1069-1078
    CrossrefPubMedGoogle Scholar
  • 30 Guo C, Ricchiuti V, Lian BQ, Yao TM, Coutinho P, Romero JR, Li J, Williams GH, Adler GK. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation 2008; 117: 2253-2261
    Google Scholar
  • 31 Luther JM, Brown NJ. The renin-angiotensin-aldosterone system and glucose homeostasis. Trends Pharmacol Sci 2011; 32: 734-739
    CrossrefPubMedGoogle Scholar
  • 32 Resch M, Bergler T, Fredersdorf S, Griese DP, Weil J, Kreuzer P, Brunner S, Riegger GA, Luchner A, Endemann DH. Hyperaldosteronism and altered expression of an SGK1-dependent sodium transporter in ZDF rats leads to salt dependence of blood pressure. Hypertens Res 2010; 33: 1082-1088
    CrossrefPubMedGoogle Scholar
  • 33 Su W, Guo Z, Randall DC, Cassis L, Brown DR, Gong MC. Hypertension and disrupted blood pressure circadian rhythm in type 2 diabetic db/db mice. Am J Physiol Heart Circ Physiol 2008; 295: H1634-H1641
    CrossrefPubMedGoogle Scholar
  • 34 Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A, Hauner H, McCann SM, Scherbaum WA, Bornstein SR. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci U S A 2003; 100: 14211-14216
    CrossrefPubMedGoogle Scholar
  • 35 Menachery A, Braley LM, Kifor I, Gleason R, Williams GH. Dissociation in plasma renin and adrenal ANG II and aldosterone responses to sodium restriction in rats. Am J Physiol 1991; 261: E487-E494
    PubMedGoogle Scholar
  • 36 Ayres PJ, Eichhorn J, Hechter O, Saba N, Tait JF, Tait SA. Some studies on the biosynthesis of aldosterone and other adrenal steroids. Acta Endocrinol (Copenh) 1960; 33: 27-58
    PubMedGoogle Scholar
  • 37 Zhang Y, Nadeau M, Faucher F, Lescelleur O, Biron S, Daris M, Rheaume C, Luu-The V, Tchernof A. Progesterone metabolism in adipose cells. Mol Cell Endocrinol 2009; 298: 76-83
    CrossrefPubMedGoogle Scholar
  • 38 MacKenzie SM, Huda SS, Sattar N, Fraser R, Connell JM, Davies E. Depot-specific steroidogenic gene transcription in human adipose tissue. Clin Endocrinol (Oxf) 2008; 69: 848-854
    CrossrefPubMedGoogle Scholar
  • 39 MacKenzie SM, Connell JMC, Davies E. Non-adrenal synthesis of aldosterone: A reality check. Mol Cell Endocrinol 2012; 350: 163-167
    CrossrefPubMedGoogle Scholar
  • 40 Swierczynska MM, Mateska I, Peitzsch M, Bornstein SR, Chavakis T, Eisenhofer G, Lamounier-Zepter V, Eaton S. Changes in morphology and function of adrenal cortex in mice fed a high-fat diet. Int J Obes Lond 2015; 39: 321-330
    CrossrefPubMedGoogle Scholar
  • 41 Maeda K, Yasunari K, Sato EF, Inoue M. Enhanced oxidative stress in neutrophils from hyperlipidemic guinea pig. Atherosclerosis 2005; 181: 87-92
    CrossrefPubMedGoogle Scholar
  • 42 Stirban A, Nandrean S, Gotting C, Stratmann B, Tschoepe D. Effects of n-3 polyunsaturated fatty acids (PUFAs) on circulating adiponectin and leptin in subjects with type 2 diabetes mellitus. Horm Metab Res 2014; 46: 490-492
    Article in Thieme ConnectPubMedGoogle Scholar
  • 43 Luther JM. Effects of aldosterone on insulin sensitivity and secretion. Steroids 2014; 91: 54-60
    Google Scholar
  • 44 Williams TA, Monticone S, Urbanet R, Bertello C, Giraudo G, Vettor R, Fallo F, Veglio F, Mulatero P. Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients. Mol Cell Endocrinol 2012; 355: 162-168
    Google Scholar